⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7779030 | 0.91 | LMNA (0.48) | — | |
| SCHEMBL7563578 | 0.88 | LMNA (0.46) | — | |
| SCHEMBL25219703 | 0.88 | LMNA (0.46) | — | |
| SCHEMBL29258030 | 0.88 | LMNA (0.46) | — | |
| SCHEMBL28179508 | 0.81 | PTPN1 (0.45) | — | |
| SCHEMBL79844 | 0.80 | — | — | |
| SCHEMBL17762348 | 0.79 | — | — | |
| SCHEMBL1190548 | 0.79 | — | — | |
| SCHEMBL28989063 | 0.78 | PTPN1 (0.39) | — | |
| SCHEMBL7863608 | 0.78 | PTPN1 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210214644-A1 | PERFUME PRECURSOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-15 | — | — | US | claimed |
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | claimed |
| EP-2673257-B1 | PET/SPECT AGENTS FOR APPLICATIONS IN BIOMEDICAL IMAGING | UNIV WASHINGTON (US) | 2018-07-18 | — | — | EP | claimed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | claimed |
| EP-2920225-B1 | REACTION ACCELERATOR FOR A COPOLYMERISATION , ELECTRICAL-INSULATION TAPE, ELECTRICAL-INSULATION BODY, AND CONSOLIDATION BODY | SIEMENS AG (DE) | 2017-11-29 | — | — | EP | claimed |
| US-20150361103-A1 | REACTION ACCELERATOR FOR A COPOLYMERISATION, ELECTRICAL-INSULATION TAPE, ELECTRICAL-INSULATION BODY, AND CONSOLIDATION BODY | SIEMENS AKTIENGESELLSCHAFT (DE) | 2015-12-17 | — | — | US | claimed |
| EP-2920225-A2 | REACTION ACCELERATOR FOR A COPOLYMERISATION, ELECTRICAL-INSULATION TAPE, ELECTRICAL-INSULATION BODY, AND CONSOLIDATION BODY | Siemens Aktiengesellschaft (DE) | 2015-09-23 | — | — | EP | claimed |
| US-20140343260-A1 | PET/SPECT AGENTS FOR APPLICATIONS IN BIOMEDICAL IMAGING | WASHINGTON UNIVERSITY (US) | 2014-11-20 | — | — | US | claimed |
| WO-2014118077-A2 | REACTION ACCELERATOR FOR A COPOLYMERISATION, ELECTRICAL-INSULATION TAPE, ELECTRICAL-INSULATION BODY, AND CONSOLIDATION BODY | SIEMENS AKTIENGESELLSCHAFT (DE) | 2014-08-07 | — | — | WO | claimed |
| EP-2762512-A1 | Reaction accelerator for a copolymerization, electrical insulation tape, electrical insulation body and consolidation body | Siemens Aktiengesellschaft (DE) | 2014-08-06 | — | — | EP | claimed |
| US-20040242870-A1 | Cannbichromene derivative; aids therapy | IMMUGEN PHARMACEUTICALS, INC. | 2004-12-02 | — | — | US | claimed |
| US-20030171372-A1 | Antiviral methods and compounds | IMMUGEN PHARMACEUTICALS, INC. (US) | 2003-09-11 | — | — | US | claimed |
| US-20030158191-A1 | Cannabinol derivatives | TRAVIS CRAIG R (US) | 2003-08-21 | — | — | US | claimed |
| US-6541510-B2 | Cannabichromene derivative is exposed to the virus, a host cell, or an infected cell under conditions sufficient to inhibit the replication or proliferation of the virus, especially HIV. | IMMUGEN PHARMACEUTICALS, INC. | 2003-04-01 | — | — | US | claimed |
| JP-2002539246-A | — | — | 2002-11-19 | — | — | JP | claimed |
| US-20020068738-A1 | Antiviral methods and compounds | IMMUGEN PHARMACEUTICALS, INC. | 2002-06-06 | — | — | US | claimed |
| WO-2002026728-A2 | ANTIVIRAL METHODS AND COMPOUNDS | IMMUGEN PHARMACEUTICALS, INC. (US) | 2002-04-04 | — | — | WO | claimed |
| EP-1189603-A2 | TREATMENT OF IMMUNE DISEASES LIKE HIV DISEASE AND NEOPLASTIC DISORDERS | Immugen Pharmaceuticals, Inc. (US) | 2002-03-27 | — | — | EP | claimed |
| US-6274635-B1 | ANTITUMOR AGENTS | IMMUGEN PHARMACEUTICALS INC. | 2001-08-14 | — | — | US | claimed |
| WO-2000056303-A2 | TREATMENT OF IMMUNE DISEASES | IMMUGEN PHARMACEUTICALS, INC. (US) | 2000-09-28 | — | — | WO | claimed |